FDA Approvals

Home > Health Information from A-Z > Health News > 
from

...
Title Date
Perjeta Approved for Early Stage Breast Cancer Sep 30, 2013
First Generic Version of Xeloda Approved Sep 16, 2013
New Device Approved for Enlarged Prostate Sep 16, 2013
Botox Approved as Temporary Treatment for Crow's Feet Sep 12, 2013
Abraxane Approved for Late-Stage Pancreatic Cancer Sep 6, 2013

...
...
-
image Seton is proud to have four hospitals – the only hospitals in Central Texas - that have earned the Magnet designation, the highest award for nursing excellence given by the American Nurses Association.
-